Nippon India Pharma Fund vs Mirae Asset Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8161 Cr | ₹2652 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 02 Jul 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 15% |
Expense Ratio | 1.82 | 1.92 |
Manager | Sailesh Raj Bhan | Vrijesh Kasera |
ISIN Code | INF204K01968 | INF769K01EA2 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Month | 3.22% | 2.44% |
6 Month | -1.66% | -2.63% |
1 Year | 15.92% | 17.94% |
3 Year | 24.36% | 22.16% |
5 Year | 21.57% | 21.65% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
6 Month | 1.61% | 0.6% |
1 Year | 0.28% | -1.18% |
3 Year | 22.01% | 21.46% |
5 Year | 18.54% | 17.93% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Year | 17.67% | 22.82% |
3 Year | 20.32% | 18.76% |
5 Year | 20.52% | 24.22% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Standard Deviation | 15.623% | 16.629% |
Sharp | 0.707% | 0.604% |
Beta | 0.908% | 0.974% |
Alpha | 0.486% | -1.264% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Name | Sailesh Raj Bhan | Vrijesh Kasera |
Total AUM | ₹96086 Cr | ₹12061 Cr |
Funds Managed | 5 | 4 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 1.36 | 2.93 |
Large Cap | 38.72 | 34.72 |
Mid Cap | 32.78 | 39.03 |
Small Cap | 27.14 | 23.32 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 1.36 | 0.17 |
Healthcare | 98.64 | 98.36 |
Basic Materials | - | 0.74 |
Industrials | - | 0.73 |
Top Comparisons
HDFC MNC Fund - Regular (G)
3Y Returns0%
UTI - MNC Fund - Regular Plan - Growth Option
3Y Returns14.7%
Axis Small Cap Fund Regular Growth
3Y Returns22.62%
Sundaram Small Cap Fund Regular Plan - Growth
3Y Returns24.59%
Sundaram ELSS Tax Saver Fund Regular Growth
3Y Returns17.77%
Sundaram Tax Savings Fund (Formerly Known as Principal Tax Savings Fund) Regular Growth
3Y Returns17.77%
Tata Money Market Fund-Regular Plan - Growth Option
3Y Returns7.48%
Baroda BNP Paribas Money Market Fund-Regular Plan - Growth
3Y Returns7%